LT - N-((1,2,3,5,6,7-HEXAHYDRO-S-INDACEN-4-YL)CARBAMOYL)-4,5,6,7-TETRAHYDROBENZOFURAN-2-SULFONAMIDE DERIVATIVES AND RELATED COMPOUNDS AS NLPR3 MODULATORS FOR THE TREATMENT OF MULTIPLE SCLEROSIS (MS)
EN - N-((1,2,3,5,6,7-HEXAHYDRO-S-INDACEN-4-YL)CARBAMOYL)-4,5,6,7-TETRAHYDROBENZOFURAN-2-SULFONAMIDE DERIVATIVES AND RELATED COMPOUNDS AS NLPR3 MODULATORS FOR THE TREATMENT OF MULTIPLE SCLEROSIS (MS)
Legal status
Patent not validated
Bibliographic data
Indications of the International Patent Classification (IPC)
| (51) |
INT.CL. |
C07D 307/82 |
(2013.01) |
|
|
C07D 307/82 |
(2006.01) |
|
|
C07D 491/04 |
(2006.01) |
|
|
C07D 491/04 |
(2013.01) |
|
|
A61P 3/00 |
(2018.01) |
|
|
C07D 333/62 |
(2006.01) |
|
|
C07C 311/56 |
(2006.01) |
|
|
A61P 3/04 |
(2018.01) |
|
|
A61K 31/343 |
(2006.01) |
|
|
A61P 3/10 |
(2018.01) |
|
|
A61K 31/55 |
(2006.01) |
|
|
A61P 1/04 |
(2018.01) |
|
|
A61K 31/4162 |
(2006.01) |
|
|
A61P 1/16 |
(2018.01) |
|
|
A61P 1/04 |
(2006.01) |
|
|
A61P 11/00 |
(2018.01) |
|
|
A61P 1/16 |
(2006.01) |
|
|
A61P 11/06 |
(2018.01) |
|
|
A61P 25/28 |
(2018.01) |
|
|
A61P 3/00 |
(2006.01) |
|
|
A61P 37/00 |
(2018.01) |
|
|
A61P 3/04 |
(2006.01) |
|
|
A61P 37/06 |
(2018.01) |
|
|
A61P 3/10 |
(2006.01) |
|
|
A61P 9/00 |
(2018.01) |
|
|
A61P 9/00 |
(2006.01) |
|
|
A61P 9/10 |
(2018.01) |
|
|
A61P 9/10 |
(2006.01) |
|
|
C07D 333/62 |
(2013.01) |
|
|
A61P 11/00 |
(2006.01) |
|
|
A61P 11/06 |
(2006.01) |
|
|
A61P 25/28 |
(2006.01) |
|
|
A61P 37/00 |
(2006.01) |
|
|
A61P 37/06 |
(2006.01) |
European patent
| (11) |
Number of the document |
3999496 |
| (13) |
Kind of document |
T |
| (96) |
European patent application number |
20757941.8 |
|
Date of filing the European patent application |
2020-07-16 |
| (97) |
Date of publication of the European application |
2022-05-25 |
| (45) |
Date of publication and mention of the grant of the patent |
2024-12-18
|
| (46) |
Date of publication of the claims translation |
|
PCT application
| (86) |
Number |
PCT/IB2020/000634 |
|
Date |
2020-07-16 |
PCT application publication
| (87) |
Number |
WO 2021/009566 |
|
Date |
2021-01-21 |
Priority applications
| (30) |
Number |
Date |
Country code |
|
201962875402 P |
2019-07-17
|
US |
Inventors
| (72) |
MOHAN, Raju , US
NUSS, John , US
HARRIS, Jason , US
YUAN, Shendong , US
|
Grantee
| (73) |
Zomagen Biosciences Ltd ,
662 Encinitas Blvd., Suite 250, Encinitas, CA 92024,
US
|
Title
| (54) |
N-((1,2,3,5,6,7-HEXAHYDRO-S-INDACEN-4-YL)CARBAMOYL)-4,5,6,7-TETRAHYDROBENZOFURAN-2-SULFONAMIDE DERIVATIVES AND RELATED COMPOUNDS AS NLPR3 MODULATORS FOR THE TREATMENT OF MULTIPLE SCLEROSIS (MS) |
| |
N-((1,2,3,5,6,7-HEXAHYDRO-S-INDACEN-4-YL)CARBAMOYL)-4,5,6,7-TETRAHYDROBENZOFURAN-2-SULFONAMIDE DERIVATIVES AND RELATED COMPOUNDS AS NLPR3 MODULATORS FOR THE TREATMENT OF MULTIPLE SCLEROSIS (MS) |
